II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina

Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people.

Saved in:
Bibliographic Details
Main Authors: Pollak,Felipe, Araya,Verónica, Lanas,Alejandra, Sapunar,Jorge, Arrese,Marco, Aylwin,Carmen Gloria, Bezanilla,Carmen Gloria, Carrasco,Elena, Carrasco,Fernando, Codner,Ethel, Díaz,Erik, Durruty,Pilar, Galgani,José, García,Hernán, Lahsen,Rodolfo, Liberman,Claudio, López,Gloria, Maíz,Alberto, Mujica,Verónica, Poniachik,Jaime, Sir,Teresa, Soto,Néstor, Valderas,Juan, Villaseca,Paulina, Zavala,Carlos
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2015
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000500012
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872015000500012
record_format ojs
spelling oai:scielo:S0034-988720150005000122018-10-31II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulinaPollak,FelipeAraya,VerónicaLanas,AlejandraSapunar,JorgeArrese,MarcoAylwin,Carmen GloriaBezanilla,Carmen GloriaCarrasco,ElenaCarrasco,FernandoCodner,EthelDíaz,ErikDurruty,PilarGalgani,JoséGarcía,HernánLahsen,RodolfoLiberman,ClaudioLópez,GloriaMaíz,AlbertoMujica,VerónicaPoniachik,JaimeSir,TeresaSoto,NéstorValderas,JuanVillaseca,PaulinaZavala,Carlos Intra-abdominal fat Insulin resistance Life style Metformin Risk factors Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.143 n.5 20152015-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000500012es10.4067/S0034-98872015000500012
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Pollak,Felipe
Araya,Verónica
Lanas,Alejandra
Sapunar,Jorge
Arrese,Marco
Aylwin,Carmen Gloria
Bezanilla,Carmen Gloria
Carrasco,Elena
Carrasco,Fernando
Codner,Ethel
Díaz,Erik
Durruty,Pilar
Galgani,José
García,Hernán
Lahsen,Rodolfo
Liberman,Claudio
López,Gloria
Maíz,Alberto
Mujica,Verónica
Poniachik,Jaime
Sir,Teresa
Soto,Néstor
Valderas,Juan
Villaseca,Paulina
Zavala,Carlos
spellingShingle Pollak,Felipe
Araya,Verónica
Lanas,Alejandra
Sapunar,Jorge
Arrese,Marco
Aylwin,Carmen Gloria
Bezanilla,Carmen Gloria
Carrasco,Elena
Carrasco,Fernando
Codner,Ethel
Díaz,Erik
Durruty,Pilar
Galgani,José
García,Hernán
Lahsen,Rodolfo
Liberman,Claudio
López,Gloria
Maíz,Alberto
Mujica,Verónica
Poniachik,Jaime
Sir,Teresa
Soto,Néstor
Valderas,Juan
Villaseca,Paulina
Zavala,Carlos
II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
author_facet Pollak,Felipe
Araya,Verónica
Lanas,Alejandra
Sapunar,Jorge
Arrese,Marco
Aylwin,Carmen Gloria
Bezanilla,Carmen Gloria
Carrasco,Elena
Carrasco,Fernando
Codner,Ethel
Díaz,Erik
Durruty,Pilar
Galgani,José
García,Hernán
Lahsen,Rodolfo
Liberman,Claudio
López,Gloria
Maíz,Alberto
Mujica,Verónica
Poniachik,Jaime
Sir,Teresa
Soto,Néstor
Valderas,Juan
Villaseca,Paulina
Zavala,Carlos
author_sort Pollak,Felipe
title II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
title_short II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
title_full II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
title_fullStr II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
title_full_unstemmed II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
title_sort ii consenso de la sociedad chilena de endocrinología y diabetes sobre resistencia a la insulina
description Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people.
publisher Sociedad Médica de Santiago
publishDate 2015
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000500012
work_keys_str_mv AT pollakfelipe iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT arayaveronica iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT lanasalejandra iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT sapunarjorge iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT arresemarco iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT aylwincarmengloria iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT bezanillacarmengloria iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT carrascoelena iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT carrascofernando iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT codnerethel iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT diazerik iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT durrutypilar iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT galganijose iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT garciahernan iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT lahsenrodolfo iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT libermanclaudio iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT lopezgloria iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT maizalberto iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT mujicaveronica iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT poniachikjaime iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT sirteresa iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT sotonestor iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT valderasjuan iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT villasecapaulina iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
AT zavalacarlos iiconsensodelasociedadchilenadeendocrinologiaydiabetessobreresistenciaalainsulina
_version_ 1755988489984278528